← Back to headlines
Alnylam Pharmaceuticals Announces 2030 Strategic Targets
Alnylam Pharmaceuticals has revealed its strategic targets for 2030, emphasizing the role of its drug AMVUTTRA and upcoming pipeline readouts in achieving its long-term goals.
9 Jun, 17:03 — 9 Jun, 17:03
Sources
Showing 1 of 1 sources
